Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

No articles found.

“Illumina offers a wide range of end-to-end Next Generation Sequencing solutions that are enabling discoveries thought impossible a few years ago.”

Paula Dowdy, General Manager for Europe, Middle East and Africa region, Illumina
Public Policy Projects is part of the Dorson Inform Group of companies which includes Dorson Transform.
  • Phone: 0207 8399305

Publications associated with PPP